Ethena Labs launches new UStb stablecoin backed by BlackRock's BUIDL token

Source Fxstreet
  • Ethena Labs announced the launch of the UStb stablecoin, collateralized by BlackRock and Securitize BUIDL.
  • UStb is a separate product from USDe and will function similarly to a traditional stablecoin.
  • Ethena may leverage UStb to address USDe's negative funding rate concerns.

Ethena Labs announced on Thursday that it has released a new stablecoin product, UStb. The new stablecoin will be fully collateralized by BlackRock's USD Institutional Digital Liquidity Fund (BUIDL) and function similarly to a traditional stablecoin.

Ethena's UStb stablecoin goes live

Ethena Labs, the issuer of USDe stablecoin, stated in an X post on Thursday that it has launched a new stablecoin product, UStb, backed by asset management firm BlackRock and Securitize's BUIDL tokenized fund.

UStb will function similarly to traditional stablecoins and is fully separate from Ethena's USDe. The team also aims to expand UStb to other centralized exchanges in order to offer partners a distinct choice of collateral.

"This will exist as an isolated product separate from USDe offering users and exchange partners a new product with a differentiated risk profile to USDe," Ethena Labs wrote in the post.

The launch of UStb may have been prompted by Ethena community members' concerns about USDe's stability during negative funding rate environments.

USDe maintains its price peg to the US dollar via a delta-neutral strategy that involves Ethena Labs purchasing Bitcoin/Ethereum in the spot market while opening an equivalent short position on the derivatives market. The process allows Ethena to gain yields from positive funding rates and ETH staking returns.

Funding rates are periodic payments between perpetual traders to maintain a contract's price with its spot counterpart.

A negative funding rate occurs when a contract's price falls below the spot price, indicating that short position holders have to pay long position holders.

Ethena claims that USDe has not suffered a whole week of negative funding despite bearish market conditions in the last six months.

Additionally, Ethena Labs mentioned that, based on a community decision, it may be forced to close down its hedging positions for USDe. 

In this case, it will convert all of USDe's reserve assets to UStb to curb potential risks that negative funding environments may attract.

Ethena's front end was recently compromised after a hacker broke the site's defenses. However, the protocol remained unaffected, and user funds remained intact.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Analysts Predict These 5 Meme Coins to 10x by 2025The meme coin cumulative market cap waned by 11.79% this month. But those who’ve been riding the crypto rollercoaster for years know to buy the dip.
Author  Bitcoinist
10 hours ago
The meme coin cumulative market cap waned by 11.79% this month. But those who’ve been riding the crypto rollercoaster for years know to buy the dip.
placeholder
India’s economy is tumbling, and it might take whole world down with itIndia’s economy is spiraling. The rupee is sinking like a stone, dragging with it a mix of trade deficits, shrinking capital inflows, and uncertainty. The country’s economy has quickly become so important that if it plummets, the global economy will be at stake.
Author  Cryptopolitan
10 hours ago
India’s economy is spiraling. The rupee is sinking like a stone, dragging with it a mix of trade deficits, shrinking capital inflows, and uncertainty. The country’s economy has quickly become so important that if it plummets, the global economy will be at stake.
placeholder
Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk's (NYSE: NVO) stock crashed by 19% on Dec. 20, after the company reported results from a late-stage clinical trial that it framed as a success.
Author  The Motley Fool
10 hours ago
Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk's (NYSE: NVO) stock crashed by 19% on Dec. 20, after the company reported results from a late-stage clinical trial that it framed as a success.
placeholder
Shiba Inu Has Plummeted 41% From Its 52-Week High. Is It Time to Buy?Volatility has always been a feature of the cryptocurrency markets. The collective value of all coins and tokens in existence recently hit an all-time high of nearly $3.9 trillion, but the market is in correction territory again, with a 12% drop as of this writing.
Author  The Motley Fool
14 hours ago
Volatility has always been a feature of the cryptocurrency markets. The collective value of all coins and tokens in existence recently hit an all-time high of nearly $3.9 trillion, but the market is in correction territory again, with a 12% drop as of this writing.
placeholder
Crucial Bitcoin Metric Back To Healthy Bull Levels, Analyst RevealsAn analyst has explained how an important Bitcoin indicator is back to levels that may be considered healthy for a bull-market uptrend.
Author  Bitcoinist
14 hours ago
An analyst has explained how an important Bitcoin indicator is back to levels that may be considered healthy for a bull-market uptrend.
goTop
quote